| 000 | 01411 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513070006.0 | ||
| 264 | 0 | _c19940106 | |
| 008 | 199401s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00075a023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLarson, D L | |
| 245 | 0 | 0 |
_aPossible contribution of a glutathione conjugate to the long-duration action of beta-funaltrexamine. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cNov 1993 |
||
| 300 |
_a3669-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnalgesia |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aEnkephalin, Leucine-2-Alanine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGlutathione _xchemistry |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMorphine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMuscles _xdrug effects |
| 650 | 0 | 4 |
_aNaltrexone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aReceptors, Opioid, mu _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aVas Deferens _xdrug effects |
| 700 | 1 | _aHua, M | |
| 700 | 1 | _aTakemori, A E | |
| 700 | 1 | _aPortoghese, P S | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 36 _gno. 23 _gp. 3669-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00075a023 _zAvailable from publisher's website |
| 999 |
_c8245517 _d8245517 |
||